GlassScriptPhysician profile
Victoria E Fox
NPI 1306372560
$718.06
in general payments reported to CMS, 2019-2025
12 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.06 · 2023: $109 · 2024: $223 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $315.79 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $147.63 | 2024 | |
| Ethicon US, LLC | $38.88 | 2025 | Surgicel Nu-Knit, Ethicon |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.30 | 2025 | Caplyta |
| Novo Nordisk INC | $33.94 | 2024-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $32.96 | 2024-2025 | Airsupra |
| Sumitomo Pharma America, INC. | $23.23 | 2025 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $21.06 | 2021 | |
| Becton, Dickinson and Company | $20.04 | 2024 | Bd Max System, Bd Max Instrument |
| Bayer Healthcare Pharmaceuticals INC. | $17.95 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.67 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.61 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.